Matches in Wikidata for { <http://www.wikidata.org/entity/Q85735180> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q85735180 description "article scientifique publié en 2012" @default.
- Q85735180 description "artículu científicu espublizáu n'avientu de 2012" @default.
- Q85735180 description "scientific article published on 19 December 2012" @default.
- Q85735180 description "wetenschappelijk artikel" @default.
- Q85735180 description "наукова стаття, опублікована в грудні 2012" @default.
- Q85735180 description "գիտական հոդված հրատարակված 2012 թվականի դեկտեմբերի 19-ին" @default.
- Q85735180 name "The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin" @default.
- Q85735180 name "The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin" @default.
- Q85735180 type Item @default.
- Q85735180 label "The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin" @default.
- Q85735180 label "The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin" @default.
- Q85735180 prefLabel "The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin" @default.
- Q85735180 prefLabel "The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin" @default.
- Q85735180 P1433 Q85735180-4672C36F-4253-4EEC-B545-DF8C6F2961E4 @default.
- Q85735180 P1476 Q85735180-0C988671-FBF9-4916-88A7-651432C2892E @default.
- Q85735180 P2093 Q85735180-20FA97E8-2739-46AC-B69B-AF9ADAA4E91B @default.
- Q85735180 P2093 Q85735180-53B95B4D-3A77-4A76-91BA-795FEAE5D467 @default.
- Q85735180 P2093 Q85735180-6520267B-A7E1-4C14-A3C5-B30DE6C786D6 @default.
- Q85735180 P2093 Q85735180-8F465AF6-518E-4527-B5BD-32007F8ABB2A @default.
- Q85735180 P2093 Q85735180-BB956AD3-C03F-4AFD-89D9-61E263CDDFFA @default.
- Q85735180 P2093 Q85735180-BE0286E3-5079-4D42-B75E-1C188664C8E5 @default.
- Q85735180 P2093 Q85735180-C07578B6-18EE-43E3-98FB-8EF4D87D9129 @default.
- Q85735180 P304 Q85735180-2AECABED-A457-477F-9BBD-E2BB7B2617DC @default.
- Q85735180 P31 Q85735180-234EB822-0CDC-4B06-97DB-27B9346328CB @default.
- Q85735180 P356 Q85735180-98120851-8734-4481-B459-AD275CC05597 @default.
- Q85735180 P433 Q85735180-762E6C06-AFB6-4AB4-88E7-1644F82319FD @default.
- Q85735180 P478 Q85735180-AB617D93-398A-42DE-9B2F-666A08B12DA2 @default.
- Q85735180 P50 Q85735180-0EFA2CEE-28B5-4C48-9BFA-7015A1A5A3DD @default.
- Q85735180 P577 Q85735180-0BC4166B-9C6A-4811-8893-2CD2AEF9055A @default.
- Q85735180 P698 Q85735180-3741437B-8079-4C42-825C-DEA04715087B @default.
- Q85735180 P921 Q85735180-4DC67F69-3AB9-460F-A561-AC74C9B1EA09 @default.
- Q85735180 P921 Q85735180-77549810-65CD-4077-B7AE-444803FFEE94 @default.
- Q85735180 P356 00498254.2012.751140 @default.
- Q85735180 P698 23252722 @default.
- Q85735180 P1433 Q1360678 @default.
- Q85735180 P1476 "The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin" @default.
- Q85735180 P2093 "Chang-Koo Shim" @default.
- Q85735180 P2093 "Dae-Duk Kim" @default.
- Q85735180 P2093 "In-Soo Yoon" @default.
- Q85735180 P2093 "Ji-Eon Kim" @default.
- Q85735180 P2093 "Jung Sun Kim" @default.
- Q85735180 P2093 "Min-Ho Oak" @default.
- Q85735180 P2093 "Suk-Jae Chung" @default.
- Q85735180 P304 "579-591" @default.
- Q85735180 P31 Q13442814 @default.
- Q85735180 P356 "10.3109/00498254.2012.751140" @default.
- Q85735180 P433 "7" @default.
- Q85735180 P478 "43" @default.
- Q85735180 P50 Q84841080 @default.
- Q85735180 P577 "2012-12-19T00:00:00Z" @default.
- Q85735180 P698 "23252722" @default.
- Q85735180 P921 Q18936 @default.
- Q85735180 P921 Q461809 @default.